Dishman Carbogen Amcis Faces Financial Challenges Amidst Stabilizing Stock Trends

Apr 22 2025 08:29 AM IST
share
Share Via
Dishman Carbogen Amcis has recently experienced an evaluation adjustment reflecting changes in its technical indicators, leading to a sideways stock trend. The company faces challenges, including declining operating profits and a low EBIT to Interest ratio, though institutional investor participation has slightly increased, indicating potential interest in its fundamentals.
Dishman Carbogen Amcis, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects notable shifts in its technical indicators. The stock's technical trend has transitioned to a sideways movement, indicating a period of stability without clear momentum in either direction.

Key financial metrics reveal a challenging landscape for the company. Over the past five years, Dishman Carbogen has experienced a decline in operating profits, with a compound annual growth rate (CAGR) of -22.30%. Additionally, the company's ability to manage its debt is under scrutiny, as evidenced by a low EBIT to Interest ratio of 0.44, suggesting difficulties in servicing its obligations. The Return on Equity (ROE) stands at a modest 0.25%, highlighting limited profitability relative to shareholders' funds.

Despite these challenges, there has been a slight uptick in institutional investor participation, with a 0.77% increase in stakes over the previous quarter, bringing their collective ownership to 10.17%. This shift may indicate a growing interest in the company's fundamentals, even as it navigates a complex financial environment.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News